Pharma / Biotech

FDA Approves Ivosidenib as First-Line Therapy for AML

The agency reviewed the application for ivosidenib using its Real-Time Oncology Review pilot program.

Source link




Related posts

METHYLPHENIDATE HYDROCHLORIDE Tablet, Extended Release [AvKARE, Inc.]

Newsemia

CHERRY COUGH DROPS (Menthol) Lozenge [McKesson]

Newsemia

FORMICA 7X SPECIAL ORDER Liquid [Uriel Pharmacy Inc.]

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy